IP Verse

Stable Ivabradine Formulations - EP3025705

The patent EP3025705 was granted to Sanofi ILA Sanayi VE Ticaret Anonim Sirketi on Nov 28, 2018. The application was originally filed on Nov 25, 2014 under application number EP14194774A. The patent is currently recorded with a legal status of "Revoked".

EP3025705

SANOFI ILA SANAYI VE TICARET ANONIM SIRKETI
Application Number
EP14194774A
Filing Date
Nov 25, 2014
Status
Revoked
Jul 10, 2020
Grant Date
Nov 28, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

HGFJul 22, 2019HGFADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0534859
DESCRIPTIONEP2276742
DESCRIPTIONWO2011157720
OPPOSITIONUS2013084335
OPPOSITIONWO02051387
OPPOSITIONWO2011157720
SEARCHUS2011306598
SEARCHUS2013084335
SEARCHUS5296482

Non-Patent Literature (NPL) Citations (6) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- anonymous, "Ivabradine Mylan 5 mg and 7.5 mg film-coated tablets", Public Assessment Report Scientific discussion, NL/H/3783/001-002/DC, (20171108), pages 1 - 10, URL: https://mri.cts-mrp.eu/Human/Downloads/NL_H_3783_002_PAR.pdf, XP055626326
OPPOSITION- "Ascorbic Acid, etc", RAYMOND ROWE et al., Handbook of Pharmaceutical Excipients. 4th ed., PhP, (20030000), pages 32 - 34 , 63, 64, ISBN 978-0-85369-472-9, XP055626315
OPPOSITION- "Ascorbid acid, etc", Fielder, Fielder Encyclopaedia of Excipients. 6th ed., Editio Cantor Verlag, (20070000), pages 234, 294 - 295, ISBN 978-3-87193-346-2, XP055626313
OPPOSITION- EMA, "Procoralan 5mg film-coated tablets, Procoralan 7mg film-coated tablets", ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS, (20051025), pages 1 - 36, XP055626321
OPPOSITION- "Table 3.3.", HOWARD ANSEL et al., Pharmaceutical Dosage Forms and Delivery Systems. 7th ed., Lippincott Williams & Wilkins, (19990000), page 88, ISBN 978-0-683-30572-7, XP055626306
OPPOSITION- "Tablet production via granulation", M. E. AULTON, Pharmaceutics, The Science of Dosage Form Design. 2nd ed., CHURCHILL LIVINGSTONE, (20020000), page 403, ISBN 978-0-443-05517-3, XP055626318

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents